Razeghinejad Reza

Arman Ali, Vahedi Hadi, Jafarizadeh Ali, Moshfeghinia Reza, Talebnezhad Mohammadreza, Heydari Mojtaba et al.

This meta-analysis found digital screen use temporarily increases IOP, particularly in glaucoma patients, highlighting a potential ocular health risk requiring further study.

Zareei Athar, Razeghinejad Reza, Talebnejad Mohammad Reza, Khalili Mohammad Reza, Masoumpour Masoumeh Sadat, Shayan Zahra et al.

This study established normal interocular macular thickness differences in healthy children, finding variations typically under 13µm for total retina, aiding glaucoma diagnosis and monitoring.

Amaral Dillan Cunha, Guedes Jaime, Cruz Matheus Ribeiro Barbosa, Cheidde Lídia, Nepomuceno Matheus, Magalhães Pedro Lucas Machado et al.

This meta-analysis found GLP-1 RAs were associated with reduced glaucoma development in retrospective studies, suggesting a potential protective effect, but further research is needed.

Salouti Ramin, Azimi Ali, Meshksar Aidin, Takapouy Ramin, Ghoreyshi Maryam, Salouti Kia et al.

This study compared Corvis ST bIOP and ORA IOPcc before/after PRK, finding poor agreement. bIOP was stable post-PRK, unlike IOPcc, suggesting bIOP may be a more reliable IOP measure after refractive surgery.

Wong Jae-Chiang, Shiuey Eric J, Razeghinejad Reza, Shukla Aakriti G, Kolomeyer Natasha N, Myers Jonathan S et al.

FCNL effectively and safely lowered eye pressure, even as a last-line treatment before surgery, making it a viable option for glaucoma management.

Ten Hulzen Richard D, Wagner Isabella V, Aref Ahmad A, Provencher Lorraine M, Razeghinejad Reza, Danesh-Meyer Helen V et al.

A misplanted glaucoma minishunt was found piercing the iris and capsular bag, embedding in the cataract. This "deadbolt" effect complicates cataract surgery and highlights the importance of precise shunt placement.

Salouti Ramin, Razeghinejad Reza, Eslami Gholamreza, Zare Mousa, Salouti Kia, Ghoreyshi Maryam et al.

This study compared ORA-IOPcc and Corvis-bIOP after LASIK, finding Corvis-bIOP more stable. Neither is interchangeable, suggesting Corvis-bIOP might be better for post-LASIK IOP monitoring.

Sinha Sapna, Ganjei Allen Y, Ustaoglu Melih, Syed Zeba A, Lee Daniel, Myers Jonathan S et al.

Shiuey Eric J, Mehran Nikki A, Ustaoglu Melih, Zhang Qiang, Razeghinejad Reza, Shukla Aakriti G et al.

Netarsudil 0.02% safely and significantly lowered IOP in real-world glaucoma patients, even those on multiple medications. Hyperemia was common, but serious side effects or vision loss were rare, making it a valuable treatment option.

Shalaby Wesam Shamseldin, Bechay Joseph, Myers Jonathan S, Lee Daniel, Razeghinejad Reza, Kolomeyer Natasha Nayak et al.

This study found a low 5.3% reoperation rate within 90 days of MIGS, mainly for elevated IOP or gel microstent issues, suggesting MIGS is generally safe short-term but highlights specific complication risks.

Lee Daniel, Kolomeyer Natasha N, Razeghinejad Reza, Myers Jonathan S

In-vivo imaging now reveals real-time, dynamic changes in the eye's aqueous outflow system. This advances understanding of glaucoma's cause and treatment, moving beyond ex-vivo studies.

Sinha Sapna, Ganjei Allen Y, Ustaoglu Melih, Syed Zeba A, Lee Daniel, Myers Jonathan S et al.

This study found Baerveldt shunts caused more corneal decompensation and transplantation than Ahmed shunts in uveitic glaucoma, despite similar tube-cornea touch rates, highlighting differing safety profiles.

Razeghinejad Reza, Gonzalez-Garcia Alberto, Myers Jonathan S, Katz L Jay

A VR perimeter showed strong correlation with standard visual field tests in glaucoma patients and normals, suggesting a portable, high-performance alternative for diagnosis and monitoring.

Sinha Sapna, Ganjei Allen Y, McWatters Zoe, Lee Daniel, Moster Marlene R, Myers Jonathan S et al.

This study found Baerveldt GDDs achieved better IOP reduction and success in uveitic glaucoma than Ahmed, but with more complications like hypotony, impacting surgical choice.

Razeghinejad Reza, Lin Michael M, Lee Daniel, Katz L Jay, Myers Jonathan S

Ocular trauma causes glaucoma through diverse mechanisms like blunt injury or inflammation; understanding these is crucial for proper management to prevent vision loss.

Mehran Nikki A, Sinha Sapna, Razeghinejad Reza

This review highlights three new glaucoma drugs (latanoprostene bunod, netarsudil, and their combination) with novel mechanisms that effectively lower intraocular pressure, offering new treatment options for patients.

Martinez Patricia, Trubnik Valerie, Leiby Benjamin E, Hegarty Sarah E, Razeghinejad Reza, Savant Shravan et al.

This study found similar IOP responses to water drinking after trabeculectomy or tube shunt surgery, but systemic antihypertensives increased IOP fluctuations, highlighting medication's impact on post-surgical IOP.